ARMP / Armata Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Armata Pharmaceuticals, Inc.
US ˙ NYSEAM ˙ US04216R1023

Acțiuni restante 36,695,155 shares
Acțiuni Insider47.566.307 shares
Total Insiders43
Scorul de sentimente din interior

Insider Sentiment Score găsește companiile cumpărate de persoane din interior.

Este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de persoane interne. Modelul de scoring folosește o combinație a numărului net de persoane din interior care cumpără în ultimele 90 de zile, totalul acțiunilor cumpărate ca procent din flota și totalul acțiunilor deținute de insider. Numărul variază de la 0 la 100, numerele mai mari indicând un nivel mai ridicat de acumulare pentru semenii săi, iar 50 fiind media.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cea mai mare acumulare de persoane din interior.

Scorul de sentiment al ofițerului

Scorul de sentiment al ofițerilor găsește companii cumpărate de ofițerii corporativi.

Prin definiție, Ofițerii Corporativi sunt Corporate Insiders, dar spre deosebire de unii dintre ceilalți Insiders (10% Acționari și Membri ai Consiliului de Administrație), Ofițerii lucrează zilnic pentru companie și își folosesc banii atunci când tranzacționează . (10% acționari și membri ai consiliului de administrație sunt adesea administratori de fonduri care gestionează banii altor persoane.) Ca atare, tranzacțiile privilegiate efectuate de către ofițeri sunt mult mai semnificative și ar trebui tratate în mod corespunzător.

La fel ca Scorul Sentimentului Insider, Scorul Sentimentului Ofițerului este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de ofițeri.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cel mai mare sentiment din interior.

Valori cheie ale insiderului

Acest card arată modul în care compania se clasifică de-a lungul diferitelor valori interne. Clasamentul percentilei arată cum se compară această companie cu alte companii de pe piețele din SUA. Clasamentele mai înalte indică situații mai bune.

De exemplu, este în general acceptat că cumpărarea din interior este un indicator pozitiv, astfel încât companiile cu mai multe achiziții din interior s-ar clasa mai sus decât companiile cu mai puține achiziții din interior (sau chiar vânzări din interior).

Numărul net de persoane din interior care cumpără (clasament)

0 ( )
6076 out of 10948

Numărul net de persoane din interior care cumpără este numărul total de persoane din interior care cumpără minus numărul total de persoane din interior care au vândut în ultimele 90 de zile. Rangul percentilei este afișat aici (interval de la 0 la 100%).

Procent din flota cumpărată de persoane din interior (clasament)

0.000% ( )
5990 out of 10786

Procent of Float Bought by Insiders este numărul total de acțiuni cumpărate de insiders minus numărul total de acțiuni vândute de insiders în ultimele 90 de zile, împărțit la flota totală și înmulțit cu 100.

Graficul privind tranzacțiile privilegiate

Armata Pharmaceuticals, Inc. tranzacții privilegiate sunt prezentate în graficul următor. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. În general, este în general ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații materiale, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4.

Lista de persoane din interior și valori de profitabilitate

Acest tabel prezintă lista persoanelor din interior cunoscute și este generată automat din dosarele dezvăluite SEC. Pe lângă nume, cel mai recent titlu și desemnarea directorului, a ofițerului sau a proprietarului în proporție de 10%, oferim cele mai recente dețineri divulgate. În plus, atunci când este posibil, oferim performanța comercială istorică pentru persoane din interior. Performanța comercială istorică este o medie ponderată a performanței tranzacțiilor reale de cumpărare pe piață deschisă efectuate de către insider. Pentru mai multe informații despre cum se calculează, urmăriți acest webinar YouTube.

See our leaderboard of most profitable insider traders.

Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
Richard Bastiani Director - [D] 27.778 27.778
Igor Bilinsky Chief Operating Officer - [O] 0 0
Biogen Idec Ma Inc 10% Owner - [10%] 11.926.948 11.926.948
Biogen Inc. 10% Owner - [10%] 11.926.948 11.926.948
Jack L Bowman Director - [D] 10.500 10.500
Richard Bear 27.383
Deborah Birx Chief Executive Officer, Director - [D] [O] 212.458 212.458
Barrie J Phd Carter Executive Vice President - [O] 48.766 48.766
Jeremy Curnock Cook Director - [D] 411.105 411.105
Joseph Md Phd Davie Director - [D] 11.000 11.000
Louis Drapeau Director - [D] 10.000 10.000
Delta Dental Plan of Michigan, Inc. 10% Owner - [10%] 2.531.604 2.531.604
Delta Dental of Wisconsin, Inc. 10% Owner - [10%] 2.586.356 2.586.356
Corp Plc Elan 10% Owner - [10%] 11.626.282 11.626.282
Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
Elan International Services Ltd 10% Owner - [10%] 11.626.282 11.626.282
Paul C Grint Chief Executive Officer, Director - [D] [O] 599 599
Roger Hawley Director - [D] 10.000 10.000
Jules Haimovitz 33.000
Corp Intrexon 10% Owner - [10%] 674.169 674.169
Innoviva Strategic Opportunities LLC Director, 10% Owner - [D] [10%] 16.365.969 16.365.969
Innoviva, Inc. Director, 10% Owner - [D] [10%] 16.365.969 16.365.969
Johnson Wendy S. Interim Chief Operating Office, Director - [D] [O] 1.000 1.000
Randal J Kirk 10% Owner - [10%] 674.169 674.169
Kirk Julian P. 16.200
Odysseas D Kostas 33.000
Robin Kramer 33.000
Pierre Kyme Chief Business Officer - [O] 9.461 9.461
Nelson L Levy Director - [D] 10.070 10.070
Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat
Steven Robert Martin Chief Financial Officer - [O] 3.760 3.760
Duane Alfred Morris VP of Operations - [O] 52.288 52.288
H Stewart Parker Director - [D] 27.778 27.778
Joseph M Patti 33.000
Michael S Perry Director - [D] 411.105 411.105
Todd Patrick Chief Executive Officer, Director - [D] [O] 408.172 408.172
Peterson Todd C. 33.000
David J Poston CFO & VP Finance - [O] 36.700 36.700
Holding Co Renaissance 10% Owner - [10%] 2.531.604 2.531.604
BG Susan Robinson President and CEO - [O] 66.915 66.915
Richard Rychlik Corporate Controller and PFO - [O] 10.000 10.000
Vijay B Samant 10.900
Michael Scott Salka Chief Executive Officer, Director - [D] [O] 11.200 11.200
Schlesinger Sarah J. 33.000
Brian Varnum President and CDO - [O] 64.324 64.324

Report errors via our new Insider Auditing Tool

Înregistrări ale achizițiilor interne - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în ARMP / Armata Pharmaceuticals, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
2022-03-31 Innoviva, Inc. 5.385.208 5,0000 5.385.208 5,0000 26.926.040 4 5.4000 2.154.083 8,00
2022-02-09 Innoviva, Inc. 3.614.792 5,0000 3.614.792 5,0000 18.073.960
2021-10-29 Innoviva, Inc. 1.212.122 3,3000 1.212.122 3,3000 4.000.003
2021-03-17 Innoviva, Inc. 4.285.935 3,2500 4.285.935 3,2500 13.929.289
2021-01-26 Innoviva, Inc. 1.867.912 3,2500 1.867.912 3,2500 6.070.714

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Înregistrări ale vânzărilor din interior - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în ARMP / Armata Pharmaceuticals, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2016-12-29 KIRK RANDAL J 20.077 0,4500 20.077 0,4500 9.035 112
2016-12-29 KIRK RANDAL J 21.923 0,4500 21.923 0,4500 9.865
2016-12-28 KIRK RANDAL J 40.450 0,4700 40.450 0,4700 19.012
2016-12-28 KIRK RANDAL J 44.170 0,4700 44.170 0,4700 20.760
2016-12-27 KIRK RANDAL J 24.092 0,5100 24.092 0,5100 12.287
2016-12-27 KIRK RANDAL J 26.308 0,5100 26.308 0,5100 13.417
2005-07-26 BIOGEN INC. 2.500 0,8700 101 21,4600 2.175
2005-07-26 BIOGEN INC. 25.660 0,8600 1.040 21,2133 22.068
2005-07-26 BIOGEN INC. 11.200 0,8500 454 20,9667 9.520

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Istoricul tranzactiilor

Faceți clic pe pictograma link pentru a vedea istoricul complet al tranzacțiilor. Tranzacțiile raportate ca parte a unui plan de tranzacționare automată 10b5-1 vor avea un X în coloana marcată 10b-5.

Fişier
Data
Comerț
Data
Formă Insider Ticker Titlul de securitate Cod 10b5-1 Direct Exercițiu
Preț
Unitate
Preț
Unități
Schimbat
Valoare
Schimbat (1K)
Rămas
Opțiuni
Rămas
Acțiuni
2026-03-17 2026-03-14 4 Kyme Pierre ARMP Common Stock F - Taxes D 10,5400 -1.030 -11 9.461
2026-03-17 2026-03-14 4 Birx Deborah ARMP Common Stock F - Taxes D 10,5400 -4.919 -52 212.458
2025-07-14 2025-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2,2700 -13.637 -31 217.377
2025-04-25 2025-03-14 4 Kyme Pierre ARMP Common Stock F - Taxes D 1,9500 -1.027 -2 10.491
2025-04-25 2025-03-14 4 Birx Deborah ARMP Common Stock F - Taxes D 1,9500 -6.061 -12 231.014
2025-04-25 2024-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2,6800 -22.925 -61 237.075
2025-04-25 3/A Kyme Pierre ARMP Common Stock D 1.518
2024-06-28 3 Kyme Pierre ARMP Common Stock D 10.000
2024-03-18 2024-03-14 4 Rychlik Richard ARMP Common Stock A - Award D 10.000 10.000
2024-03-18 2024-03-14 4 Birx Deborah ARMP Common Stock A - Award D 60.000 260.000
2023-12-26 2023-12-21 4 Birx Deborah ARMP Common Stock A - Award D 200.000 200.000
2022-04-15 2022-04-13 4 Peterson Todd C. ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Schlesinger Sarah J. ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Patrick Todd ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Kramer Robin ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Kostas Odysseas D ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 PATTI JOSEPH M ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Morris Duane Alfred ARMP Stock Options (Right to Buy) A - Award D 5,11 41.000 41.000
2022-04-15 2022-04-13 4 Haimovitz Jules ARMP Stock Options (Right to Buy) A - Award D 5,11 33.000 33.000
2022-04-15 2022-04-13 4 Varnum Brian ARMP Stock Options (Right to Buy) A - Award D 5,11 240.000 240.000
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5,00 5,0000 0 0 2.692.604
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5,0000 5.385.208 26.926 16.365.969
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5,00 5,0000 1.807.396 9.037 1.807.396
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5,0000 3.614.792 18.074 10.980.761
2021-11-01 2021-10-29 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 3,3000 1.212.122 4.000 7.365.969
2021-08-03 2021-08-02 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3,82 125.000 125.000
2021-06-09 2021-06-07 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4,29 28.000 28.000
2021-06-09 2021-06-07 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4,29 28.000 28.000
2021-06-09 2021-06-07 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 4,29 28.000 28.000
2021-06-09 2021-06-07 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 4,29 28.000 28.000
2021-06-09 2021-06-07 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 4,29 28.000 28.000
2021-04-05 2021-04-01 4 Haimovitz Jules ARMP Stock Option (Right to Buy) A - Award D 4,74 30.000 30.000
2021-03-26 2021-03-25 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 5,14 112.000 112.000
2021-03-26 2021-03-25 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 5,14 28.000 28.000
2021-03-26 2021-03-25 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 5,14 112.000 112.000
2021-03-26 2021-03-25 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 5,14 56.000 56.000
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3,25 3,2500 4.285.935 13.929 6.153.847
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3,2500 4.285.935 13.929 6.153.847
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3,25 3,2500 1.867.912 6.071 1.867.912
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3,2500 1.867.912 6.071 1.867.912
2020-12-09 2020-12-08 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3,15 23.000 23.000
2020-12-09 2020-12-08 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 3,15 30.000 30.000
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Warrants to Acquire Common Stock P - Purchase D 2,87 2,8700 7.717.661 22.150 8.710.800
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Common Stock P - Purchase D 2,8700 7.717.661 22.150 8.710.800
2020-02-14 2019-05-09 5 PERRY MICHAEL S ARMP Warrant to Purchase Common Stock J - Other I 0,32 12.065,4600 -46.666 -563.047 0
2020-02-14 2019-05-09 5 COOK JEREMY CURNOCK ARMP Warrant to Purchase Common Stock J - Other I 0,32 12.065,4600 -46.666 -563.047 0
2020-02-14 2020-02-12 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4,17 27.383 27.383
2020-02-14 2020-02-12 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4,17 27.383 27.383
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1.986.278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1.986.278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1.986.278
2019-10-15 2019-10-10 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3,77 27.383 27.383
2019-05-24 2019-05-22 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 COOK JEREMY CURNOCK ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 PARKER H STEWART ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 PERRY MICHAEL S ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3,15 149.362 149.362
2019-05-24 2019-05-22 4 Bear Richard ARMP Stock Option (Right to Buy) A - Award D 3,15 27.383 27.383
2019-05-24 2019-05-22 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3,15 298.724 298.724
2019-05-24 2019-05-22 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3,15 74.681 74.681
2019-05-24 2019-05-22 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3,15 298.724 298.724
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3.736.669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2.586.356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3.736.669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2.586.356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2.586.356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3.736.669
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2.531.604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2.531.604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2.531.604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2.531.604
2019-05-16 3 Varnum Brian ARMP Common Stock D 64.324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64.324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64.324
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52.288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52.288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52.288
2019-05-16 3 Patrick Todd ARMP Common Stock D 408.172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408.172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408.172
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27.778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27.778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27.778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27.778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27.778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27.778
2018-03-26 2018-03-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 1,1000 181.820 200 411.105
2018-03-26 2017-09-19 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 105.015 229.285
2018-03-26 2017-06-29 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 5.757 124.270
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 0,57 0,1000 46.666 5 46.666
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 7,4000 46.666 345 118.513
2018-03-26 2016-06-21 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 15.057 71.847
2018-03-26 2018-03-22 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 1,1000 181.820 200 411.105
2018-03-26 2017-09-19 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 105.015 229.285
2018-03-26 2017-06-29 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 5.757 124.270
2017-12-12 2017-12-08 4 GRINT PAUL C APHB Common Stock A - Award D 0,6200 599 0 599
2017-09-12 2017-09-07 4 PERRY MICHAEL S APHB Stock Option (Right to Buy) A - Award D 0,91 10.900 10.900
2017-09-12 2017-09-07 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 0,91 10.900 10.900
2017-09-11 2017-09-07 4 DRAPEAU LOUIS APHB Stock Option (Right to Buy) A - Award D 0,91 10.900 10.900
2017-09-11 2017-09-07 4 Johnson Wendy S. APHB Stock Option (Right to Buy) A - Award D 0,91 10.900 10.900
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0,91 285.113 285.113
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0,91 190.076 190.076
2017-09-11 2017-09-07 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0,91 139.000 139.000
2017-09-11 2017-09-07 4 COOK JEREMY CURNOCK APHB Stock Option (Right to Buy) A - Award D 0,91 10.900 10.900
2017-06-01 2017-05-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0,74 87.161 87.161
2017-04-04 2017-04-01 4 Salka Michael Scott APHB Stock Option (Right to Buy) A - Award D 0,43 214.214 214.214
2017-04-04 2017-04-01 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0,43 161.290 161.290
2017-04-04 2017-04-01 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0,43 176.411 176.411
2017-01-31 3 BILINSKY IGOR APHB Common Stock D 0
2017-01-31 2017-01-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0,46 247.322 247.322
2016-12-29 2016-12-29 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0,4500 -20.077 -9 674.169
2016-12-29 2016-12-29 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0,4500 -21.923 -10 736.170
2016-12-29 2016-12-28 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0,4700 -40.450 -19 694.246
2016-12-29 2016-12-28 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0,4700 -44.170 -21 758.093
2016-12-29 2016-12-27 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0,5100 -24.092 -12 734.696
2016-12-29 2016-12-27 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0,5100 -26.308 -13 802.263
2016-12-13 2016-12-09 4 Salka Michael Scott APHB Common Stock A - Award D 0,3900 7.000 3 11.200
2016-12-13 2016-12-09 4 Martin Steven Robert APHB Common Stock A - Award D 0,3900 3.760 1 3.760
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Series B Preferred Stock C - Conversion I -2.142.857 0
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock C - Conversion I 428.571 828.571
2016-04-12 3/A COOK JEREMY CURNOCK APHB Common Stock I 120.000
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock A - Award I 4,05 35.714 35.714
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock D - Sale to Issuer I 7,00 -35.714 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock C - Conversion I -1.040.753 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 4,05 0,0010 34.184 0 34.184
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock P - Purchase I 0,8100 326.468 264 1.040.753
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 171.298 567.903
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock C - Conversion I 208.150 396.605
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 10,75 10,7500 17.114 184 17.114
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 8,2500 68.455 565 188.455
2016-01-20 3 Martin Steven Robert APHB Common Stock D 0
2016-01-20 2016-01-18 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 2,85 99.919 99.919
2015-11-09 2015-11-05 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 5,65 16.200 16.200
2015-11-09 2015-11-05 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 5,65 16.200 16.200
2015-10-07 2015-10-05 4 Johnson Wendy S. APHB Common Stock P - Purchase D 4,4270 1.000 4 1.000
2015-10-07 2015-10-06 4 DRAPEAU LOUIS APHB Common Stock P - Purchase D 4,3900 10.000 44 10.000
2015-10-06 2015-10-05 4 Salka Michael Scott APHB Common Stock P - Purchase D 4,7500 4.200 20 4.200
2015-09-23 2015-09-21 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 6,38 16.200 16.200
2015-09-23 2015-09-21 4 PERRY MICHAEL S APHB Stock Option (right to buy) A - Award D 6,38 12.800 12.800
2015-09-23 2015-09-21 4 DRAPEAU LOUIS APHB Stock Option (right to buy) A - Award D 6,38 13.800 13.800
2015-09-23 2015-09-21 4 COOK JEREMY CURNOCK APHB Stock Option (right to buy) A - Award D 6,38 38.500 38.500
2015-09-23 2015-09-21 4 Kirk Julian P. APHB Option to Purchase Common Stock A - Award D 6,38 16.200 16.200
2015-09-10 2015-09-08 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 7,46 49.965 49.965
2015-08-06 2015-08-05 4 Salka Michael Scott APHB Stock Option (right to buy) A - Award D 0,19 19.985.810 19.985.810
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Warrant to Purchase Common Stock P - Purchase I 0,22 3.484.848 3.484.848
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Common Stock P - Purchase I 0,1650 13.939.392 2.300 37.939.392
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68.000.000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68.000.000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68.000.000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64.000.000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64.000.000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64.000.000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90.000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90.000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130.000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130.000
2008-11-17 3 Robinson BG Susan TGEN Common Stock D 66.915
2007-05-21 2007-05-17 4 BOWMAN JACK L TGEN Common Stock A - Award D 10.000 10.500
2007-05-21 2007-05-17 4 CARTER BARRIE J PHD TGEN Common Stock A - Award D 35.000 48.766
2007-05-21 2007-05-17 4 COOK JEREMY CURNOCK TGEN Common Stock A - Award D 15.000 15.000
2007-05-21 2007-05-17 4 DAVIE JOSEPH MD PHD TGEN Common Stock A - Award D 10.000 11.000
2007-05-21 2007-05-17 4 HAWLEY ROGER TGEN Common Stock A - Award D 10.000 10.000
2007-05-21 2007-05-17 4 LEVY NELSON L TGEN Common Stock A - Award D 10.000 10.070
2007-05-21 2007-05-17 4 PARKER H STEWART TGEN Common Stock A - Award D 50.000 81.175
2007-05-21 2007-05-17 4 PERRY MICHAEL S TGEN Common Stock A - Award D 10.000 10.000
2007-05-21 2007-05-17 4 Poston David J TGEN Common Stock A - Award D 35.000 36.700
2005-11-02 3 PERRY MICHAEL S TGEN Common Stock D 0
2005-10-04 3 Poston David J TGEN Common Stock D 17.000
2005-08-16 3 HAWLEY ROGER TGEN Np securities held D 0
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8700 -2.500 -2 11.926.948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8600 -25.660 -22 11.929.448
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8500 -11.200 -10 11.955.108
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8300 -10.640 -9 11.966.308
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8200 -12.500 -10 11.976.948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,8100 -2.500 -2 11.989.448
2005-07-27 2005-07-25 4 BIOGEN INC. by Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0,7900 -8.500 -7 11.991.948
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 851.873
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 508.673
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 3.060.754
2005-07-12 2003-08-15 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value P - Purchase I 1,9100 2.515.843 4.805 12.127.178
2005-07-12 2002-11-06 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 1,0700 -210.819 -226 9.611.335
2005-07-12 2002-09-30 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 0,5500 104.854 58 9.400.516
2005-01-10 2005-01-06 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7500 -43.600 -76 11.626.282
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7500 -225.335 -394 11.669.882
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7600 -14.465 -25 11.895.217
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,8000 -10.200 -18 11.909.682
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7000 -77.919 -132 11.919.882
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7100 -1.750 -3 11.997.801
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7200 -7.591 -13 11.999.551
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7500 -24.500 -43 12.007.142
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7600 -3.800 -7 12.031.642
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7700 -20.690 -37 12.035.442
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,7800 -6.400 -11 12.056.132
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,8000 -1.400 -3 12.062.532
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1,8100 -950 -2 12.063.932
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Series B Convertible Exchangeable Preferred Stock C - Conversion I 3,32 -12.015 0
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Common Stock C - Conversion I 3,3200 4.330.000 14.376 12.064.882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Series B Convertible Exchangeable Preferred Stock J - Other I 3,32 0
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2,09 302.934,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2,80 63.420,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1,88 190.800,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,57 127.200,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,49 134.832,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,65 57.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,83 180.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,96 120.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1,19 127.200,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1,95 950.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2,48 3.000.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3,78 2.000.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3,70 120.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 6,11 2.000.000,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2,09 302.934,0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0,4900 277.775 136 7.734.882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0,5700 221.757 126 7.457.106
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0,6500 87.922 57 7.235.349
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0,8300 217.549 181 7.147.427
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0,9600 124.630 120 6.929.878
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1,1900 107.044 127 6.805.248
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1,8800 101.439 191 6.698.204
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1,9500 487.248 950 6.596.765
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 2,0900 3.577.879 7.478 6.109.517
2003-11-05 2003-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2,80 63.420,0000
2003-11-05 2003-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1,88 190.800,0000
2003-11-05 2003-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,57 127.200,0000
2003-11-05 2003-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,49 134.832,0000
2003-11-05 2003-02-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,65 57.000,0000
2003-11-05 2002-12-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,83 180.000,0000
2003-11-05 2002-10-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0,96 120.000,0000
2003-11-05 2002-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1,19 127.200,0000
2003-11-05 2002-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 1,95 950.000,0000
2003-11-05 2002-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 2,48 3.000.000,0000
2003-11-05 2002-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 3,78 2.000.000,0000
2003-11-05 2002-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3,70 120.000,0000
2003-11-05 2001-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 6,11 2.000.000,0000
2003-11-05 2000-08-09 4 ELAN CORP PLC N/A TGEN Common Stock P - Purchase I 13,0640 382.739 5.000 2.531.638
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:TG1N 6,45 EUR
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista